Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7484 p4
5/12 January 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


PM pledges to strengthen screening and prevention

Stefan Rousseau/PA Wire/PA Photos

Gordon Brown

Gordon Brown said that availability of screening tests would be extended

Screening, prevention and strengthened commissioning are to be the basis of continuing reform of the NHS in England, Prime Minister Gordon Brown stated this week.

Speaking to health professionals at King’s College London, Mr Brown said that tests to identify vulnerability to heart and circulation problems will be introduced, alongside check-ups to monitor for heart disease, stroke, diabetes and kidney disease.

In addition, GP surgeries will provide diagnostic procedures, such as blood tests, electrocardiograms and ultrasounds.

He also said the Government would commit to providing any screening procedures that the National Screening Committee recommended would be genuinely useful. “Wherever they recommend a new form of screening on clinical grounds, we will make it available to everyone, not — as happens too often now — just those who can pay.”

He also said that any preventive vaccines currently in development would be offered on the NHS wherever they are needed and when there is a clinical case for making them available.

Health minister Ben Bradshaw later confirmed that pharmacists would have an important role to play in the planned screening initiatives. Georgina Craig, head of communications and partnership development at the Company Chemists’ Association, told The Journal that she was pleased to see pharmacy recognised in this commitment.

However, she stressed, the only way to enable pharmacy-based screening to be rolled out would be to have it introduced as an advanced service. That is what the CCA hopes will happen, she said.

The Royal Pharmaceutical Society has also stressed the importance of pharmacy involvement in the initiatives. David Pruce, director of practice and quality improvement, commented: “Pharmacists already have expertise in patient screening, and it makes sense that these further screening plans are rolled out in the pharmacy. … Utilising the skills of pharmacists provides an opportunity to free GPs, who don’t have the time or capacity to screen patients and provide further follow up.”

In his speech, Mr Brown also said that more must be done to make NHS organisations responsive to patients’ needs and to ensure funding not only follows patients through treatment but also prevents illness. “We will strengthen commissioning, give more responsibility to primary care professionals and open up primary care: with more providers, new primary care services, and more weekend and evening access.”

He also said that foundation trusts would be given the freedom to provide primary care services where this is in the interests of patients.

Back to Top


©The Pharmaceutical Journal